# fep-benchmark
Benchmark set for relative free energy calculations.

Created by Christina Schindler and Daniel Kuhn, Merck KGaA, Darmstadt, Germany.

December 2018

Manuscript in preparation.

Previously presented at Alchemical Free Energy Workshop 2019 in Goettingen, Germany.

DOI: [10.5281/zenodo.3258925](https://doi.org/10.5281/zenodo.3258925)

## References for datasets used in benchmark

### c-Met
Dorsch, Dieter, et al. 
"Identification and optimization of pyridazinones
 as potent and selective c-Met kinase inhibitors." 
Bioorganic & medicinal chemistry letters 25.7 (2015): 1597-1602.

DOI: [10.1016/j.bmcl.2015.02.002](https://doi.org/10.1016/j.bmcl.2015.02.002)

### Eg5
Schiemann, Kai, et al. 
"The discovery and optimization of hexahydro-2H-pyrano
 [3, 2-c] quinolines (HHPQs) as potent and selective inhibitors
 of the mitotic kinesin-5." 
 Bioorganic & medicinal chemistry letters 20.5 (2010): 1491-1495.
 
 DOI: [10.1016/j.bmcl.2010.01.110](https://doi.org/10.1016/j.bmcl.2010.01.110)
 
 ### Hif2a
Wallace, Eli M., et al. 
"A small-molecule antagonist of HIF2α is efficacious
in preclinical models of renal cell carcinoma." 
Cancer research 76.18 (2016): 5491-5500.

DOI: [10.1158/0008-5472.CAN-16-0473](https://doi.org/10.1158/0008-5472.CAN-16-0473)

Dixon, Darryl David, et al. 
"Aryl ethers and uses thereof." U.S. Patent No. 9,908,845. 6 Mar. 2018.

URL: [Google Patents](https://patents.google.com/patent/US9908845B2)

### PFKFB3
Boutard, Nicolas, et al. 
"Discovery and Structure–Activity Relationships of N-Aryl 
6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors."
ChemMedChem 14.1 (2019): 169-181.
 
 DOI: [10.1002/cmdc.201800569]( https://doi.org/10.1002/cmdc.201800569)
 
### SHP2
Chen, Ying-Nan P., et al. 
"Allosteric inhibition of SHP2 phosphatase inhibits cancers
 driven by receptor tyrosine kinases." Nature 535.7610 (2016): 148.
 
 DOI:[10.1038/nature18621](https://doi.org/10.1038/nature18621)
 
Garcia Fortanet, Jorge, et al. 
"Allosteric inhibition of SHP2: identification of a potent, selective,
and orally efficacious phosphatase inhibitor."
Journal of medicinal chemistry 59.17 (2016): 7773-7782.

DOI: [10.1021/acs.jmedchem.6b00680](https://doi.org/10.1021/acs.jmedchem.6b00680)

Chen, Christine Hiu-tung, et al. 
"1-pyridazin-/triazin-3-yl-piper (-azine)/idine/pyrolidine derivatives
and compositions thereof for inhibiting the activity of shp2." 
U.S. Patent Application No. 15/110,498.

URL: [Google Patents](https://patents.google.com/patent/US10093646B2)
